BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-21 out of 21 found
  Current Search:  fs: 21, shampoo: 197     

HTML
57%
Life Sciences: Findings from Brown University, Department of Neuroscience broaden understanding of life sciences
Today's Medical & Research News Life Sciences Findings from Brown University, Department of Neuroscience broaden understanding of life sciences March 16th, 2010 Printer-Friendly Version City:Providence State:RI Country:United States Life Sciences Brown...
NewsRX:  Mar 16 2010 4:03AM
Matching: fs
Find similar documents
HTML
57%
Seeing an 'A' Raises Test Scores
Certain Letters of the Alphabet Can Affect Achievement, Study Shows WebMD Health News March 12, 2010 -- Simply seeing the letter A before an exam might help you improve your grade, but spotting an F could make you perform poorly.

This finding comes from a...

WebMD:  Mar 15 2010 5:21PM
Matching: fs
Find similar documents
HTML
57%
BMG Labtech to Showcase the PHERAstar FS Reader and Other Microplate Readers at Analytica 2010
From the beginning, BMG Labtech, the microplate reader company, has understood that automation is a key feature in high-throughput screening and has designed all of its microplate reader instrumentation to be easily automated.

Stop by hall B1, booth number...

Pharmaceutical Technology:  Mar 14 2010 8:23PM
Matching: fs
Find similar documents
HTML
57%
Increase in GP training places to meet needs
Aoife Connors talks to the ICGP and HSE about the plan to increase the number of GP training places Last week, the HSE and the Irish College of General Practitioners (ICGP) announced a 30 per cent increase in the number of GP training places across the country....
Irish Medical Times:  Mar 12 2010 6:25AM
Matching: fs
Find similar documents
HTML
57%
BMG LABTECH Is Proud To Announce Their Participation At The Analytica 2010
BMG LABTECH to showcase the PHERAstar FS reader and other microplate readers designed for automation platforms at the Analytica 2010.

From the beginning, BMG LABTECH the microplate reader company - has understood that automation is a key feature in high...

Bioresearch Online:  Mar 11 2010 10:57AM
Matching: fs
Find similar documents
HTML
57%
Novel Criteria To Differentiate Fibrosis From Steatohepatitis
Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world.

Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients.

However, it is an invasive procedure, with...

Medical News Today:  Mar 8 2010 10:53AM
Matching: fs
Find similar documents
HTML
57%
Differentiation of cirrhosis from inflammation in patients with ALD: Novel bedside criteria identified
Alcoholic liver disease (ALD) is the most common cause of liver cirrhosis in the Western world.

Liver biopsy is currently considered the gold standard for assessing hepatic fibrosis or cirrhosis in these patients.

However, it is an invasive procedure, with...

News-Medical.Net:  Mar 6 2010 9:14AM
Matching: fs
Find similar documents
HTML
57%
March blood pressure clinics are scheduled
Western Illinois Home Health Care, Inc.

of Monmouth is offering FREE Blood Pressure Screenings throughout the month in the Fulton County area.

Various clinics have been set up in the area to contribute to the health and well being of the area citizens.

Canton Daily Ledger:  Mar 3 2010 12:49AM
Matching: fs
Find similar documents
HTML
57%
Optimization of magnetic resonance sequences in lymph node staging of nasopharyngeal carcinoma
Chen YB et al.

For the detection of retropharyngeal and cervical lymph nodes, coronal STIR sequence and axial PDWI fs sequence have similar performance and both sequences showed better detection than CE FSE T1WI fs sequence.

Optimization of...

MDLinx:  Feb 26 2010 10:42AM
Matching: fs
Find similar documents
HTML
57%
Myocardial Performance in Asphyxiated Full-Term Infants Assessed by Doppler Tissue Imaging
Matter M et al.

A higher cTnT was a significant predictor of mortality, whereas fractional shortening (FS) and DTI measurements did not show any significant predictive value.

Myocardial Performance in Asphyxiated Full-Term Infants Assessed by Doppler...

MDLinx:  Feb 25 2010 10:21AM
Matching: fs
Find similar documents
HTML
57%
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Mirza FS et al.

The findings suggest that serum sclerostin levels are regulated by both estrogens and PTH in postmenopausal women.

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal...

MDLinx:  Feb 24 2010 12:47PM
Matching: fs
Find similar documents
HTML
57%
Study shows favorable results of femtosecond laser over microkeratome LASIK
Differences were found in terms of vision recovery time, best corrected visual acuity, and rates of intraoperative and postoperative complications.

A comparison between femtosecond LASIK and microkeratome LASIK in a large series of patients showed that...

OSN Super Site:  Feb 24 2010 10:22AM
Matching: fs
Find similar documents
HTML
57%
Hedge Fund Manager Paulson's Big Banking Bet Continues (DJ)
Hedge Fund Manager Paulson's Big Banking Bet Continues By Joseph Checkler Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Hedge fund manager John Paulson's Paulson & Co.

continued adding to his stakes in big U.S.

banks during the fourth quarter.

Easy Bourse:  Feb 17 2010 12:38AM
Matching: fs
Find similar documents
HTML
57%
Icahn Cut Yahoo Stake Again During The Fourth Quarter (DJ)
By Joseph Checkler Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Hedge fund manager Carl Icahn accelerated his selling of Yahoo Inc.

(YHOO) shares during the fourth quarter of 2009, according to regulatory filings.

Icahn cut his Yahoo stake to 12 million...

Easy Bourse:  Feb 13 2010 7:35AM
Matching: fs
Find similar documents
HTML
57%
Icahn Cut Yahoo Stake Again During The Fourth Quarter
NEW YORK -(Dow Jones)- Hedge fund manager Carl Icahn accelerated his selling of Yahoo Inc.

(YHOO) shares during the fourth quarter of 2009, according to regulatory filings.

Icahn cut his Yahoo stake to 12 million shares during the quarter, down from 62.9...

FOXNews.com:  Feb 13 2010 2:10AM
Matching: fs
Find similar documents
HTML
57%
Icahn Cut Yahoo Stake Again During The Fourth Quarter
NEW YORK -(Dow Jones)- Hedge fund manager Carl Icahn accelerated his selling of Yahoo Inc.

(YHOO) shares during the fourth quarter of 2009, according to regulatory filings.

Icahn cut his Yahoo stake to 12 million shares during the quarter, down from 62.9...

FOXBusiness.com:  Feb 13 2010 1:45AM
Matching: fs
Find similar documents
HTML
57%
Icahn Cut Yahoo Stake Again During The Fourth Quarter
NEW YORK -(Dow Jones)- Hedge fund manager Carl Icahn accelerated his selling of Yahoo Inc.

(YHOO) shares during the fourth quarter of 2009, according to regulatory filings.

Icahn cut his Yahoo stake to 12 million shares during the quarter, down from 62.9...

Morningstar.com:  Feb 13 2010 12:44AM
Matching: fs
Find similar documents
HTML
57%
Icahn Cut Yahoo Stake Again During The Fourth Quarter
NEW YORK -(Dow Jones)- Hedge fund manager Carl Icahn accelerated his selling of Yahoo Inc.

(YHOO) shares during the fourth quarter of 2009, according to regulatory filings.

Icahn cut his Yahoo stake to 12 million shares during the quarter, down from 62.9...

Nasdaq:  Feb 12 2010 11:53PM
Matching: fs
Find similar documents
HTML
57%
Potent Method for the Simultaneous Determination of Glutathione and Hydrogen Peroxide in Mitochondrial Compartments of Apoptotic Cells with Microchip Electrophoresis-Laser Induced Fluorescence
College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Engineering Research Center of Pesticide and Medicine Intermediate Clean Production, Ministry of Education, Shandong Normal...
Analytical Chemistry:  Feb 10 2010 6:42AM
Matching: fs
Find similar documents
HTML
57%
Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII Following Interim Analysi
- Study will not be able to meet primary endpoint / Bayer remains committed to developing its long-acting recombinant factor VIII compounds; alternative candidates in development Berlin, January 25, 2010 - Bayer Schering Pharma AG, Germany has announced that an...
Pharma Live:  Jan 25 2010 4:25PM
Matching: fs
Find similar documents
HTML
57%
Bayer Discontinues Phase II Liplong Study
Bayer Schering Pharma has announced that an independent Data Safety and Monitoring Board (DSMB) has completed an interim analysis of a phase II trial (the Liplong study) of the companys long-acting recombinant factor VIII, BAY79-4980.

The DSMB concluded that...

Pharmaceutical Business Review:  Jan 25 2010 12:15PM
Matching: fs
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.